Our Business

Currently we operate in emerging markets with our distribution partners and in house brands.

We are open for out licensing / co development / other models of collaboration, as we expand our footprints to highly regulated markets. We at Sanzyme are fully aware and prepared of dynamic regulatory landscape in the segment of Biologics / Biosimilars.

Armed with EU GMP & PIC/s for its Finished Formulations, Sanzyme offers its e-CTD to cater to global regulatory requirements.

Our Current Markets*

  • Nigeria
  • Morocco
  • Francophone countries
  • Kenya
  • Tanzania
  • Mauritius
  • Libya
  • Philippines
  • Malaysia
  • Sri Lanka
  • Myanmar
  • Nepal
  • Vietnam
  • Pakistan
  • Thailand
  • Myanmar
  • Indonesia
  • Uzbekistan
  • Tajikistan
  • Syria
  • Iraq
  • Bahrain
  • Yemen
  • Jordan
  • Russia
  • Moldova
  • Poland
  • Dominican Republic

* Markets registered or under registration

For further enquiries, please contact:

USA, EU and LATAM

Mr. Navneet Battu (Vice President – International Business)
(navneet.battu@sanzyme.com)

CIS Region

Mr. Pradeep Bagaadi (pradeep.b@sanzyme.com)
and
Mr. Navneet Battu (navneet.battu@sanzyme.com)

South East Asia / APAC

Mr. Yamini Prasad (yaminiprasad.kandru@sanzyme.com)
and
Mr. Navneet Battu (navneet.battu@sanzyme.com)

Middle-East and North Africa

Mr. Pundeep Chaparala (pundeep.chaparala@sanzyme.com)
and
Mr. Navneet Battu (navneet.battu@sanzyme.com)

Rest of Africa

Mr. Amit Kumar Sharma (amitkumar.sharma@sanzyme.com)
and
Mr. Navneet Battu (navneet.battu@sanzyme.com)